Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 17 September 2026
Baxdrostat for treating uncontrolled or resistant hypertension [ID6623]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 14 April 2027
Renal sympathetic denervation for resistant hypertensionStatus:In developmentProgramme:HealthTech guidanceExpected publication date: TBC